Creating value together


We are looking at out-licensing our innovative solutions in order to help outside partners gain access to novel solutions and speed up time-to-market.

30%+ turnover invested in 2019
30% + turnover invested in 2019

Invested in Research & Development

7+ products
7+ products

Currently approved and marketed products in several disease areas (Gastroenterology, allergology, gynecology and dermatology)

20+ scientific research
20+ scientific research based projects and a prospective global expansion

We continue to discover and develop our technology in new disease areas

60+ countries
60+ countries

Where our products are approved and marketed that certify their quality and innovativeness.


Continuous improvement and R&D investment
Medical and scientific
Regulatory support for registration
Working ethically and accountably

Long-term licensing agreement
Product and territory exclusivity


Gain access to novel solutions & speed up time-to-market
 with current portfolio
Sales & Marketing engine
Focused & Driven

Creating value together